(Q33456742)

English

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Epstein–Barr virus

0 references

Good manufacturing practice

1 reference

based on heuristic

inferred from title

Jacqueline Barry

7

object named as

Jacqueline Barry

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Mark A Vickers

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Gwen M Wilkie

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nicolas Robinson

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nadja Rivera

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tanzina Haque

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dorothy H Crawford

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Neil Fraser

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

David M Turner

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Victoria Robertson

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phil Dyer

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Flanagan

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Helen R Newlands

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

John Campbell

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marc L Turner

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

26 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

167

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

402-410

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

EBV-positive diffuse large B-cell lymphoma of the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

EBV-associated lymphomas in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Epstein-Barr virus-associated gastric carcinoma: a newly defined entity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

How I treat EBV lymphoproliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232001

21 June 2018

Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13051

21 January 2018

Identifiers

10.1111/BJH.13051

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33456742&oldid=2088894113"